Episode Details

Danaher (DHR) — Q4 2025 Earnings Deep Dive. Danaher is at an inflection point: bioprocessing orders are reaccelerating after a destocking cycle, a transformational $9. In this episode of Charged Alpha (Ep. 137), we cover Danaher's latest earnings, financials, valuation, analyst consensus, and the bull vs. bear case. Free research tools: https://chargedalpha.com. Not financial advice. AI-assisted production.